InvestorsHub Logo
icon url

BonelessCat

04/23/18 6:44 PM

#225785 RE: frrol #225783

You’re right, it’s not a complex molecule. But, it is for multiple modes of delivery: oral rinse, retention enema (likely a foam), IV. Upcoming, oral delivery. Manufacturing and packaging for those commercial uses are more complex than a small molecule would suggest. This is getting out ahead of the curve for a potential partner saving both future time and money. One less worry for a partner.
icon url

PlentyParanoid

04/24/18 5:45 AM

#225831 RE: frrol #225783

Ffrol, and you think Dr. Reddy (IPIX's previous CMO) doing manufacturing would not be cause of concern. It seems that Mezzion and FDA strongly disagree.